Barely Significant
← all excerpts

The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung Cancer.

Cancers (Basel) · 2023 · PMC10778520 · PMID 38201583

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

did not reach statistical significancep = 0.0500actually significant
Although there was a trend towards lower pneumonectomy rates in patients treated with chemoimmunotherapy, the difference did not reach statistical significance (OR: 0.76, 95% CI: 0.57–1.00, p = 0.0500) ( Figure S6 ).

also in 59,377 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.